News from the healthcare data industry
The ability to harness vast amounts of health data using advanced AI technology will lead to new discoveries and insights needed to improve patient care March 14, 2022 09:00 AM Eastern Daylight Time SUNNYVALE, Calif.–(BUSINESS WIRE)–Cerebras Systems, the pioneer in high performance artificial intelligence (AI) compute, and nference, an AI-driven health…
WASHINGTON—Today, the U.S. Senate Health, Education, Labor, and Pension (HELP) Committee advanced the PREVENT Pandemics Act, which includes seven bills and additional provisions led by U.S. Senator Bill Cassidy, M.D. (R-LA). Dr. Cassidy’s bills prepare America to face future pandemics, by strengthening our Strategic National Stockpile, and increasing coordination between our public health infrastructure and health care system. The PREVENT Pandemics Act passed the HELP Committee 20-2 and…
Advanced techniques for generating real-world evidence (RWE) help pharmaceutical companies deliver insights that transform outcomes for patients—and create significant value. McKinsey estimates that over the next three to five years, an average top-20 pharma company could unlock more than $300 million a year by adopting advanced RWE analytics across its value chain. Opportunities…
An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking. Read more: HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2022/03/14/PHARMA-LEADERS-SHOULD-STEP-UP-ON-ARTIFICIAL-INTELLIGENCE-CONCERTAI
An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking. Read more: HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2022/03/14/PHARMA-LEADERS-SHOULD-STEP-UP-ON-ARTIFICIAL-INTELLIGENCE-CONCERTAI
The ability to harness vast amounts of health data using advanced AI technology will lead to new discoveries and insights needed to improve patient care March 14, 2022 09:00 AM Eastern Daylight Time SUNNYVALE, Calif.–(BUSINESS WIRE)–Cerebras Systems, the pioneer in high performance artificial intelligence (AI) compute, and nference, an AI-driven health…
SHANGHAI, March 14, 2022 /PRNewswire/ — Asieris Pharmaceuticals (688176.SH), a global innovative biopharma company specializing in discovering and developing innovative drugs for the treatment of genitourinary tumors and other major diseases, announced that the Hainan Provincial Medical Products Administration, in accordance with advice from the National Medical Products Administration Center for Drug Evaluation (CDE),…
Combined technologies strengthen Clarify’s leadership, creating the most comprehensive end-to-end value-based payments solution March 14, 2022 09:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health, a leading cloud analytics and value-based payments platform company, announced today the acquisition of Embedded Healthcare, a behavior change platform company created by healthcare leaders…
Program open at no-cost to any academic researcher interested in submitting a proposal March 10, 2022 08:00 AM Eastern Standard Time OXFORD, England–(BUSINESS WIRE)–Exscientia (Nasdaq: EXAI) and the University of Oxford Target Discovery Institute (Oxford TDI) today announced the formation of Xcellomics – a program designed to source cellular functional assays from the…
When inspecting clinical trials that incorporate real-world data, the UK medicines regulator says that its good clinical practice (GCP) inspectors expects sponsors to be able to demonstrate that the RWD database they used was suitable for the study and of sufficient quality. As inspectors, “it’s certainly not our intention to…